As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.
Company says it received conditional approval for bird flu vaccine from US Department of Agriculture
The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an outbreak of a newer variant ravages poultry flocks, contributing to the sky high price of eggs.
USDA conditionally approves bird flu vaccine
The United States Department of Agriculture conditionally approved a vaccine to mitigate the spread of bird flu amongst America’s poultry and other animals.
Zoetis gets Conditional License for Bird Flu Vaccine
Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.
A bird flu vaccine for chickens is on its way
In a bid to contain a bird flu outbreak that has sent egg prices soaring, the U.S. Department of Agriculture (USDA) last week granted a conditional license for a vaccine designed to protect chickens from the virus.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Zoetis price target lowered to $200 from $225 at BTIG
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Why Zoetis Stock Took Another Tumble Today
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Bank of America Securities Sticks to Their Buy Rating for Zoetis (ZTS)
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...
Hosted on MSN7d
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
Animal health company Zoetis (NYSE:ZTS) in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, ...
Why Zoetis Stock Was Falling Today
Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
William Blair Brokers Reduce Earnings Estimates for Zoetis
Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Zoetis to Participate in Upcoming Investor Conferences
Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor ...